PHD PERSPECTIVES & METHODOLOGY

Category: Bioinformatics & Discovery

Methodological perspectives on medical writing, PRISMA 2020 evidence synthesis, multi-omics target validation, and R&D documentation from our PhD leadership.

All Articles (3) Bioinformatics & Discovery (2) Evidence Synthesis & Methodology (1)

Bioinformatics & Discovery 6-minute read

Biomarkers Are Not Drug Targets, and Why That Distinction Costs the Industry Billions

Why conflating correlative disease signatures with upstream causal perturbation nodes leads to late-stage clinical attrition — and how multi-omics and single-cell perturbation analyses separate the two.

Debasis (Dev) Sahu, PhD
January 15, 2024

Read article →

Bioinformatics & Discovery 5-minute read

AI as Tool vs AI as Inventor: Why the Distinction Will Decide the Next Decade of Patents

Patent offices worldwide require documented human inventive contribution. Here is how computational drug discovery and degrader (PROTAC / LyTAC) teams should structure their R&D audit trails.

Debasis (Dev) Sahu, PhD
January 18, 2024

Read article →